Avalo Therapeutics, Inc.

8-K Director or officer change Jun 23, 2026 8-K Other events Jun 16, 2026 8-K Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws Jun 12, 2026 8-K Director or officer change; Shareholder vote results Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure May 7, 2026 8-K Other events May 5, 2026 8-K Entered a material agreement; Regulation FD disclosure Apr 28, 2026 8-K Director or officer change Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Results of operations (earnings release) Mar 23, 2026 8-K Results of operations (earnings release); Other events Jan 12, 2026 8-K Other events Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Oct 29, 2025 8-K Other events Oct 10, 2025 8-K Director or officer change; Other events Oct 1, 2025 8-K Director or officer change Sep 22, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events Jun 20, 2025 8-K Director or officer change; Other events Jun 18, 2025 8-K Shareholder vote results Jun 17, 2025 8-K Entered a material agreement; Terminated a material agreement Jun 5, 2025 8-K Other events Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Other events May 8, 2025 8-K Director or officer change; Other events Mar 26, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Other events Jan 13, 2025 8-K Director or officer change; Other events Jan 2, 2025 8-K Other events Dec 5, 2024 8-K Other events Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Oct 8, 2024